Patents by Inventor Robert BROTHERS

Robert BROTHERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10813941
    Abstract: A pharmaceutical composition includes a small molecule and a pharmaceutically acceptable excipient. The small molecule interacts with a deoxyxylulose phosphate reductoisomerase (Dxr). A method for treating or preventing a microbial infection in a subject in need thereof includes administering the pharmaceutical composition. A method for inhibiting the growth of a eukaryotic pathogen includes contacting the eukaryotic pathogen with an effective amount of the pharmaceutical composition.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: October 27, 2020
    Assignees: The George Washington University, A Congressionally Chartered Not-For-Profit Corporation, Washington University in St. Louis
    Inventors: Cynthia Dowd, Audrey Odom, Rachel Edwards, Robert Brothers
  • Publication number: 20190030056
    Abstract: A pharmaceutical composition includes a small molecule and a pharmaceutically acceptable excipient. The small molecule interacts with a deoxyxylulose phosphate reductoisomerase (Dxr). A method for treating or preventing a microbial infection in a subject in need thereof includes administering the pharmaceutical composition. A method for inhibiting the growth of a eukaryotic pathogen includes contacting the eukaryotic pathogen with an effective amount of the pharmaceutical composition.
    Type: Application
    Filed: January 23, 2017
    Publication date: January 31, 2019
    Applicants: THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALL A CONGRESSIOY CHARTERED NOT-FOR-PROFIT CORPORATIO, WASHINGTON UNIVERSITY IN ST. LOUIS
    Inventors: Cynthia DOWD, Audrey ODOM, Rachel Edwards, Robert BROTHERS